Press Releases

All

March 7, 2022

Rakuten Medical Announces New Name “Alluminox™” for its Proprietary Technology Platform

February 15, 2022

Rakuten Medical and Shimadzu Enroll First Patient in the U.S. Clinical Trial of Photoimmunotherapy

January 5, 2022

Rakuten Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 10th, 2022

December 15, 2021

Rakuten Medical Announces FDA Acceptance of an Investigational New Drug (IND) Application for RM-1995, a Conjugate of IR700 and anti-CD25 Antibody

October 27, 2021

Data from Phase 1/2a study of RM-1929 Photoimmunotherapy in Patients with Recurrent Head and Neck Squamous Cell Carcinoma was Published in Head and Neck

« Previous 1 … 6 7 8 9 10 … 16 Next »

Year Archive

2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Related Content

About Us

About Us
Letter from Our CEO
Leadership
Location

About

About
Letter from Our CEO
Leadership
Location

Pipeline

Pipeline
Expanded Access Program

Pipeline

Pipeline
Expanded Access Program

News

News
Press Releases
Rakuten Medical Stories
Press Kit

News

News
Press Releases
Rakuten Medical Stories
Press Kit

Contact

Privacy Policy

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We use cookies to enhance user experience and to analyze performance and website traffic. View our Privacy Policy for more details.

Cookie Settings Accept All Cookies

Privacy & Cookies Policy

Privacy Overview

We use cookies to enhance user experience and to analyze performance and website traffic. View our Privacy Policy for more details.
Do not sell my personal information

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages. Keeping this cookie enabled helps us to improve our website.

SAVE & ACCEPT